Chemomab Therapeutics Ltd.

CMMB

Held by 1 specialist biotech fund

1 fund opened new positions. Short interest: 0.7% of float.

Share

Signal Score

1.2/10

1 fund opened new positions

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

OrbiMed Advisors

Position history (shares)

OrbiMed Advisors

2Q

2 quarters

Position Trend

May 15, 2025

$1.9M

1 fund

Aug 14, 2025

$1.1M

1 fund

Nov 14, 2025

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Short Interest

Short Shares

41K

Change

+95.3%

Days to Cover

0.4

% of Float

0.7%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Position Details

OrbiMed AdvisorsEXITFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

3 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

APLS1 fund ARGX1 fund CTMX1 fund ACET1 fund PTCT1 fund ADCT1 fund MLYS1 fund PRAX1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer